Application 214735
- Type
- ANDA
- Sponsor
- GRANULES
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | GLYCOPYRROLATE | GLYCOPYRROLATE | SOLUTION;ORAL | 1MG/5ML | No | No |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| A214735-001 | GLYCOPYRROLATE | GLYCOPYRROLATE | 1MG/5ML | SOLUTION / ORAL | AA | 2024-08-19 |
Therapeutic equivalence codes#
| Application-product | TE code |
|---|---|
| A214735-001 | AA |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-11-14 07:37:17 | 2026-10 | A214735-001 | GLYCOPYRROLATE | 1MG/5ML | SOLUTION / ORAL | AA | 2024-08-19 | d4dbc9d85df4… | |
| 2026-10-15 13:18:30 | 2026-09 | A214735-001 | GLYCOPYRROLATE | 1MG/5ML | SOLUTION / ORAL | AA | 2024-08-19 | c2088c7a36db… | |
| 2026-09-14 22:38:34 | 2026-08 | A214735-001 | GLYCOPYRROLATE | 1MG/5ML | SOLUTION / ORAL | AA | 2024-08-19 | 84e616aacf4f… | |
| 2026-08-18 06:07:40 | 2026-07 | A214735-001 | GLYCOPYRROLATE | 1MG/5ML | SOLUTION / ORAL | AA | 2024-08-19 | caaa826d4ba7… | |
| 2026-02-19 14:30 UTC | 2026-02 | A214735-001 | GLYCOPYRROLATE | 1MG/5ML | SOLUTION / ORAL | AA | 2024-08-19 | 011fe1cb6892… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A214735-001 | GLYCOPYRROLATE | 1MG/5ML | SOLUTION / ORAL | AA | 2024-08-19 | 31067a03dcf5… | |
| 2025-08-23 18:47 UTC | 2025-08 | A214735-001 | GLYCOPYRROLATE | 1MG/5ML | SOLUTION / ORAL | AA | 2024-08-19 | 6a471c1ec25d… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A214735-001 | GLYCOPYRROLATE | 1MG/5ML | SOLUTION / ORAL | AA | 2024-08-19 | fd3edfee7708… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A214735-001 | GLYCOPYRROLATE | 1MG/5ML | SOLUTION / ORAL | AA | 2024-08-19 | b8a1b40f171c… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A214735-001 | GLYCOPYRROLATE | 1MG/5ML | SOLUTION / ORAL | AA | 2024-08-19 | 03ed91905a0d… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A214735-001 | GLYCOPYRROLATE | 1MG/5ML | SOLUTION / ORAL | AA | 2024-08-19 | 2680178bc6a6… | |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A214735-001 | GLYCOPYRROLATE | 1MG/5ML | SOLUTION / ORAL | AA | 2024-08-19 | 5bbf6a4d5a75… | |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A214735-001 | GLYCOPYRROLATE | 1MG/5ML | SOLUTION / ORAL | AA | 2024-08-19 | d8e5a09893c0… | |
| 2024-10-29 15:01 UTC | 2024-10 | A214735-001 | GLYCOPYRROLATE | 1MG/5ML | SOLUTION / ORAL | AA | 2024-08-19 | d06236e962d9… | |
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | A214735-001 | GLYCOPYRROLATE | 1MG/5ML | SOLUTION / ORAL | AA | 2024-08-19 | a50c72e98297… |
Observed Orange Book normalized TE history#
| Captured | Edition | Application-product | TE code | Order | Source SHA-256 |
|---|---|---|---|---|---|
| 2026-11-14 07:37:17 | 2026-10 | A214735-001 | AA | 1 | d4dbc9d85df4… |
| 2026-10-15 13:18:30 | 2026-09 | A214735-001 | AA | 1 | c2088c7a36db… |
| 2026-09-14 22:38:34 | 2026-08 | A214735-001 | AA | 1 | 84e616aacf4f… |
| 2026-08-18 06:07:40 | 2026-07 | A214735-001 | AA | 1 | caaa826d4ba7… |
| 2026-02-19 14:30 UTC | 2026-02 | A214735-001 | AA | 1 | 011fe1cb6892… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A214735-001 | AA | 1 | 31067a03dcf5… |
| 2025-08-23 18:47 UTC | 2025-08 | A214735-001 | AA | 1 | 6a471c1ec25d… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A214735-001 | AA | 1 | fd3edfee7708… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A214735-001 | AA | 1 | b8a1b40f171c… |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A214735-001 | AA | 1 | 03ed91905a0d… |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A214735-001 | AA | 1 | 2680178bc6a6… |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A214735-001 | AA | 1 | 5bbf6a4d5a75… |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A214735-001 | AA | 1 | d8e5a09893c0… |
| 2024-10-29 15:01 UTC | 2024-10 | A214735-001 | AA | 1 | d06236e962d9… |
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | A214735-001 | AA | 1 | a50c72e98297… |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Glycopyrrolate | GLYCOPYRROLATE | Medical Purchasing Solutions, LLC | 9c9666bf-841b-03fa-e053-2a95a90abb48 | 2023-05-11 | Warnings, Adverse reactions | Glycopyrrolate GLYCOPYRROLATE |
| Glycopyrrolate | GLYCOPYRROLATE | Medical Purchasing Solutions, LLC | 9e5113b7-1c0c-24bd-e053-2995a90ab94b | 2023-05-09 | Warnings, Adverse reactions | Glycopyrrolate GLYCOPYRROLATE |
| Glycopyrrolate | GLYCOPYRROLATE | Medical Purchasing Solutions, LLC | bbf0abe2-8deb-19b2-e053-2a95a90a60a3 | 2023-05-08 | Warnings, Adverse reactions | Glycopyrrolate GLYCOPYRROLATE |
| Glycopyrrolate | GLYCOPYRROLATE | Medical Purchasing Solutions, LLC | b622f21f-fa37-1259-e053-2995a90aa796 | 2023-05-04 | Warnings, Adverse reactions | Glycopyrrolate GLYCOPYRROLATE |
| GLYCOPYRROLATE | GLYCOPYRROLATE | Medical Purchasing Solutions, LLC | a2a2a03f-21cc-5fec-e053-2995a90a84cb | 2023-05-03 | Warnings, Adverse reactions | GLYCOPYRROLATE GLYCOPYRROLATE |
| Glycopyrrolate | GLYCOPYRROLATE | LGM PHARMA SOLUTIONS, LLC | 392a969d-1e14-4ad8-835c-a47be4983067 | 2023-04-27 | Warnings, Adverse reactions | Glycopyrrolate GLYCOPYRROLATE |
| Glycopyrrolate | GLYCOPYRROLATE | Medical Purchasing Solutions, LLC | e8bb95ed-09f1-fcf1-e053-2a95a90a93e5 | 2023-04-25 | Warnings, Adverse reactions | Glycopyrrolate GLYCOPYRROLATE |
| Glycopyrrolate | GLYCOPYRROLATE | Medical Purchasing Solutions, LLC | ea4c8be4-a1e9-5901-e053-2995a90a5e63 | 2023-04-24 | Warnings, Adverse reactions | Glycopyrrolate GLYCOPYRROLATE |
| Glycopyrrolate | GLYCOPYRROLATE | Civica, Inc. | 3ac4f32f-f5ca-4a6d-9bc7-2672d478b3d4 | 2023-03-01 | Warnings, Adverse reactions | Glycopyrrolate GLYCOPYRROLATE |
| Glycopyrrolate | GLYCOPYRROLATE | Meitheal Pharmaceuticals Inc. | 02f914a8-2356-4525-91ff-cf0c9e41ba23 | 2023-01-12 | Warnings, Adverse reactions | Glycopyrrolate GLYCOPYRROLATE |
| GLYCOPYRROLATE | GLYCOPYRROLATE | Quinn Pharmaceuticals | e1ded8e0-c05b-4bf4-a129-57d1726af6ed | 2022-12-20 | Warnings, Adverse reactions | GLYCOPYRROLATE GLYCOPYRROLATE |
| Glycopyrrolate | GLYCOPYRROLATE | Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. | 26cdd84d-ffa0-4e52-b359-4acef4bd8093 | 2022-11-10 | Warnings, Adverse reactions | Glycopyrrolate GLYCOPYRROLATE |
| Glycopyrrolate | GLYCOPYRROLATE | Camber Pharmaceuticals, Inc. | 4741be85-3abb-4545-aba9-281f64d210ec | 2022-07-13 | Warnings, Adverse reactions | Glycopyrrolate GLYCOPYRROLATE |
| GLYCOPYRROLATE | GLYCOPYRROLATE | Novadoz Pharmaceuticals LLC | 98820c01-1853-45d8-9da5-875fcdf5f9ab | 2022-06-14 | Warnings, Adverse reactions | GLYCOPYRROLATE GLYCOPYRROLATE |
| Glycopyrrolate | GLYCOPYRROLATE | Xiromed LLC | 29618edf-39b0-022a-9875-9d865450d318 | 2022-04-12 | Warnings, Adverse reactions | Glycopyrrolate GLYCOPYRROLATE |
| Glycopyrrolate | GLYCOPYRROLATE | Xiromed, LLC | f777c813-3232-d744-8bcf-58e86fb929bd | 2022-04-12 | Warnings, Adverse reactions | Glycopyrrolate GLYCOPYRROLATE |
| Glycopyrrolate | GLYCOPYRROLATE | Hikma Pharmaceuticals USA Inc. | 516cc4f8-3583-4405-ab66-29d4fcc56d05 | 2022-03-23 | Warnings, Adverse reactions | Glycopyrrolate GLYCOPYRROLATE |
| Glycopyrrolate | GLYCOPYRROLATE | Hikma Pharmaceuticals USA Inc. | d5a18d74-0d40-46e2-aa0a-41d18609a536 | 2022-03-04 | Warnings, Adverse reactions | Glycopyrrolate GLYCOPYRROLATE |
| glycopyrrolate | GLYCOPYRROLATE | BE Pharmaceuticals Inc. | d9df3900-a8c2-438b-8971-ba11ff91f90b | 2022-02-24 | Warnings, Adverse reactions | glycopyrrolate GLYCOPYRROLATE |
| Glycopyrrolate | GLYCOPYRROLATE | Somerset Therapeutics, LLC | a46c5ec1-a1b4-46fc-9b37-8da7f0c983d6 | 2022-01-27 | Warnings, Adverse reactions | Glycopyrrolate GLYCOPYRROLATE |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.